Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Cameroon Country Profile

Cameroon Country Profile

Discover more about CDC’s work in Cameroon by viewing our detailed country profile

Country Overview

CDC and the Government of Cameroon began a partnership in 2008 to support the development of sustainable public health capacity and infrastructure in the country. Initially providing purely technical leadership, CDC’s role has evolved to include direct clinical support and assistance to the Ministry of Health and local non-governmental organizations to scale-up access to HIV prevention and treatment in order to achieve HIV epidemic control. CDC also continues to support the Ministry in the areas of epidemiology, surveillance, laboratory, operations research, and workforce capacity development.

$1,400

Per Capita GNI

23.4 (2016)

Population (million)

80/1000 (2016)Live Births

Under 5 Mortality

58 years (2016)

Life Expectancy

(Ages 15-49): 5.1%

Estimated HIV Prevalence

26,000 (2016)

Estimated AIDS Deaths

340,000

Estimated Adults and Children living with HIV

197,000 (2016)

Reported Number Receiving Antiretroviral Therapy (ART)

203/100,000 (2016)

Estimated TB Incidence

34% (2016)

TB patients with known HIV-status who are HIV-positive

84% (2015)

TB Treatment Success Rate


Strategic Focus

Maximizing Unique Government-to-Government Relationships with the Ministry of Health (MoH): The Centers for Disease Control and Prevention (CDC) and the Government of the Republic of Cameroon (GRC) began a partnership in 2008 to support the development of sustainable public health capacity and infrastructure. CDC’s role has evolved from solely providing technical leadership to now including direct clinical support and assistance to the Ministry of Health (MOH).

Strengthening Public Health Systems: CDC provides expert public health science leadership and direct assistance to the MOH and local non-governmental organizations to prevent, detect and respond to public health challenges while strengthening epidemiology, surveillance, laboratory, operations research, HIV prevention and treatment programs, and workforce capacity development. CDC-Cameroon’s HIV program strategy focuses on increasing antiretroviral treatment (ART), prevention of mother-to-child HIV transmission (PMTCT), strengthening laboratories, linkages to treatment, and strategic information.

Key Activities and Accomplishments

Treatment Scale up: CDC Cameroon’s U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) specific priorities include scaling-up access to HIV prevention and treatment to achieve HIV epidemic control. Cameroon’s Accelerating Children’s HIV/AIDS Treatment (ACT) initiative has made great strides in providing ART to children. Through a strong partnership, MOH has approved test and start and task shifting policies and delivery of ART medications for adults and children living with HIV. Tuberculosis (TB) remains a major cause of morbidity and mortality for people living with HIV (PLHIV). CDC supports HIV testing among TB patients to ensure access to early ART to prevent AIDS-related morbidity and mortality; and TB screening and provision of isoniazid preventive therapy (IPT) to prevent TB morbidity among PLHIV.

Laboratory Capacity: National Public Health Laboratory (NPHL) renovation is complete and the national strategic laboratory plan was enhanced in 2018; CDC launched and implemented the first national proficiency testing program (PT), which currently has over 800 laboratories enrolled for HIV rapid testing, and CDC assisted with the implementation and roll out of the Strengthening Laboratory Improvement Process towards Accreditation (SLIPTA) with one laboratory obtaining SANAS Accreditation and 13 laboratories currently enrolled in the accreditation process. CDC provided technical assistance and laboratory support to set up and build the capacity of two laboratories for DNA/RNA polymerase chain reaction testing, one of which is now the first SANAS ISO-15189 Accredited laboratory for Cameroon and Central Africa. Both laboratories currently serve as national reference laboratories for early infant diagnosis and viral load testing services to support the country’s treatment program.

Strategic Information: CDC has supported improvements in the national HIV/AIDS monitoring and evaluation (M&E) system and harmonization of M&E registers and data collection tools with close to 25,000 registers printed and distributed nationally. CDC is strengthening Cameroon’s Health Information System through technical and financial support for the customization, piloting, and rollout of District Health Information Software (DHIS) at national, regional, and district levels. The Cameroon Population-based HIV Impact Assessment (CAMPHIA) completed data collection in February 2018 and results will inform HIV strategic planning and decision-making.


Social Media Card

CDC study provides new evidence that Drug-Resistant Tuberculosis is set to rise in some of the world’s highest burden countries …

Social Media Card

TB is the #1 killer of people living with HIV. TB preventative treatment protects those with HIV from contracting TB Disease. it’s effective, it’s affordable. it saves lives

Social Media Card

CDC’s innovative efforts to Find, Cure, and Prevent TB are creating a safer America and a safer world.

TOP